Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry ; volume:25 ; number:1 ; day:19 ; month:9 ; year:2023 ; pages:1-13 ; date:12.2023
Arthritis Research & Therapy ; 25, Heft 1 (19.9.2023), 1-13, 12.2023
- Urheber
-
Jung, Ju-Yang
Lee, Eunyoung
Kim, Ji-Won
Suh, Chang-Hee
Shin, Kichul
Kim, Jinhyun
Kim, Hyoun-Ah
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-023-03165-w
- URN
-
urn:nbn:de:101:1-2024020710450838633478
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jung, Ju-Yang
- Lee, Eunyoung
- Kim, Ji-Won
- Suh, Chang-Hee
- Shin, Kichul
- Kim, Jinhyun
- Kim, Hyoun-Ah
- SpringerLink (Online service)
Ähnliche Objekte (12)
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Intestinal tuberculosis masquerading as difficult to treat Crohn disease: a case report
Endotyping Difficult-to-Treat Chronic Rhinosinusitis with Nasal Polyps by Structured Histopathology
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Intestinal tuberculosis masquerading as difficult to treat Crohn disease: a case report
Endotyping Difficult-to-Treat Chronic Rhinosinusitis with Nasal Polyps by Structured Histopathology
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Intestinal tuberculosis masquerading as difficult to treat Crohn disease: a case report